This educational activity is designed to incorporate evidence-based pathophysiology, diagnosis, and/or treatment of surgical disorders into clinical practice. Speakers will utilize their personal, institutional and evidence-based experience to address patient health care conditions requiring clinical and surgical treatment. Speakers will also utilize departmental quality improvement data, M&M data, and patient safety data to improve outcomes of surgical disease and other aspects of surgical patients’ general health. Evidence-based data regarding the changing aspects/newer approaches to surgical disease will be analyzed, and critical issues related to surgery within the broader scope of American health care will be discussed.
There are varying degrees to individuals’ knowledge regarding clinical and surgical treatments. While individuals may be aware of varied treatment within the surgeons’ armamentarium it is beneficial to address the topics from an evidence-based approach. Learners should both have the knowledge base and be able to apply this knowledge into their practice.
Grand Rounds will address each of these shortcomings by utilizing nationally known experts in the field. Each week will provide diverse information pertaining to these issues.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
General Surgeons, Physician Assistants, Allied Health Care Professionals
The Objective of the lecture is to review novel strategies aimed at drug-free transplantation, or “transplant tolerance”. Stem cell mobilization from the recipient’s own bone marrow has been shown to repopulate a transplanted organ and lead to conversion of the transplant to self, thus eliminating the need for toxic immunosuppression. The lecture will review the laboratory evidence for this phenomenon and the possibility for application in patients.”
A. Joseph Tector, MD, PhD
The First Mark B. Adams, MD, Memorial Lectureship
Professor of Surgery
Director of Xenotransplantation Program
University of Alabama at Birmingham
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.